This report on two patients with hypoglycemia and increased 6MMP provides an interesting discussion of management of this unusual but significant problem. The description of the use of allopurinol along with the biochemical rationale for using the drug is very helpful, and should be of value to pediatric hematologists. The discussion, including the possibility of altering the effectiveness of chemotherapy, is fair and balanced, as well. 